Chinese biophysicist Rao Zhihe has been appointed the hub’s first strategic scientist as a Chinese innovation hub steps up collaboration with Thailand in health and life sciences. The appointment puts a named scientist at the center of a cross-border research push that runs through universities, industry leaders and a forum organized by the Association of Pacific Rim Universities. The machinery of cooperation looks polished. The power behind it is clear enough: institutions deciding where knowledge moves, who gets access, and how fast it travels.
Who Holds the Keys
Rao has been working on natural anti-Covid products with Mahidol University researchers. That work sits inside a larger arrangement where elite institutions coordinate biomedical research across borders while ordinary people wait for the results. Early in the coronavirus pandemic, Rao and his team identified two parts of the virus that could be targeted by drugs and shared the information with scientists around the world. He said, “We shared them with more than 300 universities, research institutes and companies that approached our team before the findings were published.”
That number matters. More than 300 universities, research institutes and companies got the information before publication, through a network built for speed, access and influence. The article says Rao shared the findings in the hope of speeding up the development of effective drugs. The language is clinical. The structure is not. Knowledge moved through institutional channels first, and only then toward the public-facing record.
Rao, a professor at Tsinghua and ShanghaiTech universities, said that in an interview in Bangkok last month on his first trip abroad in three years. He said the world “desperately” needed a broad-spectrum and effective antiviral drug, which his team was working towards, for the ongoing and future coronavirus pandemics, and that joint efforts from international scientists were key. The need is real. So is the hierarchy that decides which scientists get the platform, which universities get the access, and which partnerships get celebrated as progress.
What They Call Cooperation
He also said, “I believe China and Thailand have good room for cooperation,” during the forum, which was organised by the Association of Pacific Rim Universities. The forum brought together industry and university leaders to discuss cross-border biomedical research partnerships in the Asia-Pacific region. That’s the official script: collaboration, partnership, regional coordination. The article doesn’t describe public clinics, community labs or mutual aid networks. It describes industry and university leaders setting the terms.
The forum’s purpose was to discuss how biomedical research partnerships in the Asia-Pacific region could help to prevent the next pandemic. That framing puts prevention in the hands of institutions with resources, credentials and access. The people most exposed to the next outbreak don’t appear as decision-makers here. They appear only as the reason the system says it must keep expanding.
The Public Gets the Promise
Rao’s team is working towards a broad-spectrum and effective antiviral drug for the ongoing and future coronavirus pandemics. That’s the promise. The article gives no timeline, no public distribution plan and no detail on how ordinary people will control the results. Instead, it centers a hub, a forum, a professor, a strategic scientist and a set of institutional partnerships linking China and Thailand.
The article says the innovation hub is helping China step up collaboration with Thailand in health and life sciences. Step up, in this case, means more coordination among universities, companies and organized research bodies. The arrangement may produce useful science. It also shows how tightly knowledge is managed when the powerful decide collaboration should happen through their own channels first.
The virus didn’t ask permission. The institutions did what institutions do: they organized access, named the experts, and turned a public health emergency into another arena for managed cooperation. The people at the bottom still have to live with the outcome.